Digital Therapeutic

SAN FRANCISCO — An artificial intelligence-derived biomarker enabled improved risk stratification for men with high-risk prostate cancer, according to study results presented at ASCO Genitourinary Cancers Symposium.

A mobile app called the Dialysis Pocket Assistant was well received by patients on dialysis needing assistance with diet adherence in Poland, according to data published in the Journal of Renal Nutrition.

A home-based cardiac rehabilitation program improved functional capacity and was associated with regaining occupation and reduced dependence on disability benefits, researchers reported.

A deep-learning artificial intelligence model led to a “significant increase in diagnostic performance” for radiologists distinguishing between acute diverticulitis and colon cancer via CT images, according to results in JAMA Network Open.

MIAMI BEACH, Fla. — Artificial intelligence should be thoughtfully evaluated for the use of skin cancer detection, according to a presenter at South Beach Symposium.

A smartphone enabled machine-learning algorithm may be as effective as a neurologist in identifying signs and symptoms of acute stroke, according to preliminary research presented at International Stroke Conference.

Radiation therapy is the most common treatment for lung cancer, the most frequently diagnosed type of cancer worldwide.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Savas Komban, CEO and co-founder of Smartlens, discusses developments in unmet needs in glaucoma, including IOP assessment.

Mobile optometry company 20/20 Onsite is making clinical trials more accessible to patients in the United States with the creation of modular, full-service mobile vision pods, the company announced in a press release.

Medical technology company LivaNova has announced the launch of SenTiva Duo, an implantable pulse generator that provides vagus nerve stimulation therapy for patients with drug-resistant epilepsy.